Тетравит

Quick links to important sections

Тетравит

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Тетравит

Quick Facts

Property Description
Active Ingredient Retinol (A), Cholecalciferol (D₃), Tocopherol (E), Essential Fatty Acids (F)
Form Oil solution, Capsules
Pharmacological Class Polyvitamin Complex / Metabolic Regulator
Common Use Prophylaxis and correction of vitamin deficiencies
Origin Synthetic and/or Semisynthetic in Oil Base

Тетравит is a Combined Vitamin Preparation that functions as a Metabolic Regulator, supplying a fixed, synergistic combination of essential fat-soluble vitamins to the body. It is categorized within the pharmacological class of Polyvitamin Complexes, and its specific composition is clinically recognized for addressing dietary gaps that lead to widespread vitamin deficiency.


What Type of Preparation is Тетравит?

Тетравит is an official pharmaceutical product containing four key fat-soluble vitamins: A (Retinol), D₃ (Cholecalciferol), E (Tocopherol), and F (Essential Fatty Acids). As a Combined Product, it represents a therapeutic approach distinct from single-vitamin therapy, formulated to ensure the simultaneous intake of these micronutrients, which are often required together for optimal biological function. This positions the product as a specialized option for individuals facing deficiencies predominantly in the lipid-soluble vitamin category.


Composition, Active Ingredients, and Physical Form

The core of Тетравит is its active composition of Retinol, Cholecalciferol, Tocopherol, and Essential Fatty Acids. The preparation uses these synthetic and/or semisynthetic compounds which are necessarily dissolved in a neutral, Vegetable Oil Base. This oil base is crucial, as the fat-soluble nature of vitamins A, D₃, and E mandates the presence of lipids for effective absorption and bioavailability. The resulting formulation is primarily made available as an Oil solution for Oral or Intramuscular administration, in addition to Capsules.


What is the General Health Purpose of Тетравит?

The general purpose of Тетравит is to serve as a prophylactic and corrective agent for conditions associated with hypovitaminosis. By restoring levels of these essential micronutrients, the preparation supports critical metabolic functions, including cellular protection through antioxidant activity (Vitamin E), regulation of Calcium-Phosphorus homeostasis (Vitamin D₃), and maintenance of epithelial tissue integrity (Vitamin A). The role of this specific combined complex is to promote general functional health, particularly in scenarios of increased physiological demand or restricted dietary intake.

Regulatory References

  1. MedlinePlus on Vitamins

What side effects are possible with Тетравит?

Possible side effects and safety information

The safety profile for polyvitamin complexes containing fat-soluble vitamins A, D, and E (such as Тетравит) is primarily defined by the risk of Hypervitaminosis A and Hypervitaminosis D, which occurs from excessive accumulation with high-dose or prolonged use. Regulatory documents classify documented adverse effects by the affected physiological system.


Adverse Reactions and Systemic Classification

Adverse reactions that have been officially documented span several System-Organ Classes. These include Nervous System Disorders (such as headache and dizziness), Gastrointestinal Disorders (including nausea, vomiting, and abdominal pain), and Skin and Subcutaneous Tissue Disorders (such as dry skin or hair loss, typically linked to chronic exposure). Reactions such as generalized hypersensitivity are documented, though their specific frequency in multivitamin complexes is often categorized as Not Known in regulatory documentation.


Serious Safety Concerns and Restrictions

Serious Adverse Reactions officially associated with toxicity include Increased Intracranial Pressure (Pseudotumor Cerebri), Hypercalcemia (excessive blood calcium levels), and significant Hepatic Damage. The preparation is contraindicated in patients with a pre-existing state of Hypervitaminosis (A or D), known hypersensitivity to any component, or conditions leading to hypercalcaemia.

Population-Specific Notes

Specific safety considerations are documented for certain populations. For pregnancy, official labels include warnings regarding the teratogenic effects (congenital malformations) associated with excessive Vitamin A intake. Patients with severe renal impairment or hepatic disease may face an increased risk of toxicity and are subject to specific safety limitations outlined in the official prescribing information.

Overdose and Emergency Response

The official regulatory profile for Тетравит overdose is defined by Hypervitaminosis, a state resulting from the toxic accumulation of its fat-soluble components, Retinol (Vitamin A) and Cholecalciferol (Vitamin D₃). This toxicity affects multiple systems, including the neurological, renal, and hematologic.

  • Documented Overdose Presentations: Acute Retinol toxicity symptoms may include severe headache, vomiting, and skin peeling. Chronic toxicity can be marked by fatigue, hair loss, and potential liver damage. Cholecalciferol toxicity is characterized by hypercalcemia, leading to excessive thirst, frequent urination, nausea, and confusion. High doses of Tocopherol (Vitamin E) are associated with a documented risk of increased bleeding and hemorrhage.
  • Severe Outcomes and Required Action: Overdose can lead to life-threatening complications such as kidney failure, cardiac arrhythmias, and cerebral edema. Children and pregnant women (due to teratogenic risk from Vitamin A) represent specific populations with documented overdose considerations.
  • Emergency Response: The immediate action required is the discontinuation of the product. Immediate medical attention is mandated if severe symptoms (persistent vomiting, confusion, signs of hemorrhage, or renal distress) occur. No specific pharmacological antidote is known. Management is symptomatic and supportive, often requiring specialized monitoring of electrolytes and renal function to mitigate the toxic effects.

Therapeutic Uses of Тетравит

Тетравит is a multi-vitamin combination preparation that is intended for use in addressing conditions linked to a deficit of specific fat-soluble vitamins. The primary therapeutic goal is to help manage symptoms associated with hypovitaminosis A, D, and E, or conditions where the nutritional requirement for these components is elevated.

The preparation is commonly utilized as supportive care in clinical scenarios such as: various dermatological issues related to vitamin A status (e.g., dry skin), bone health concerns and muscle discomfort linked to vitamin D status, and for maintaining normal vision. It may also be considered to support the body's status during periods of high physical demands or following certain recovery phases.


Quick Fact: Symptom Support Тетравит may assist in the maintenance of normal eyesight and the integrity of epithelial tissues.


Eligibility and Restrictions for Use

The eligibility for using the Polyvitamin Complex Тетравит is strictly defined by regulatory warnings concerning fat-soluble vitamin toxicity and population vulnerability, rather than its intended use.

Contraindicated Populations

Use is absolutely contraindicated for patients who have:

  • Existing Hypervitaminosis A or Hypervitaminosis D (vitamin toxicity), as the product’s components could worsen the condition.
  • A documented hypersensitivity or allergy to Retinol (Vitamin A), Cholecalciferol (Vitamin D₃), Tocopherol (Vitamin E), Essential Fatty Acids, or any other excipient in the formulation.
  • Pregnancy status, due to the teratogenic risk associated with the Retinol component, which can cause harm to the fetus.

Restricted and Limited Use

Official prescribing information dictates limited use for specific populations:

  • Nursing mothers are generally not recommended to use the preparation, due to the potential for hypervitaminosis in the infant via breast milk.
  • Pediatric patients below the minimum established age threshold (e.g., typically under 11 years for analogous formulations) are not recommended as safety and efficacy for the fixed-ratio combination have not been established by regulators.
  • Patients with Hepatobiliary Dysfunction or conditions predisposing them to Hypercalcemia must use the product with caution and under restricted monitoring, as these conditions impact the safe metabolism and systemic levels of the vitamins.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The formulation of Тетравит, which contains polyvalent mineral ions (such as Calcium, Iron, Magnesium, and Zinc) and high-dose fat-soluble vitamins (A and D), makes it susceptible to several clinically relevant interactions with other medicines.


Reduced Absorption via Chelation

Tetracycline and Fluoroquinolone Antibiotics

The metal ions in this product form insoluble, non-absorbable complexes (chelates) with certain oral antibiotics, specifically tetracyclines (e.g., Doxycycline) and fluoroquinolones (e.g., Ciprofloxacin). This interaction significantly reduces the absorption and therapeutic concentration of the antibiotic, potentially leading to treatment failure. To mitigate this effect, administration of the antibiotic and Тетравит must be separated by at least 2 hours.


Risk of Hypercalcemia

Thiazide Diuretics and other Vitamin D Preparations

Concomitant use with thiazide diuretics (which reduce calcium excretion) or other high-dose preparations of Vitamin D increases the risk of developing hypercalcemia (excessively high calcium levels in the blood). Other multivitamin products containing high doses of Vitamin D should generally be avoided.


Other Potential Interactions

  • Anticoagulants: The effect of coumarin-derivative anticoagulants (e.g., Warfarin) may be potentiated, potentially increasing the risk of bleeding. Close monitoring is advised.
  • Absorption Blockers: Mineral oil-type laxatives and Colestyramine may impair the absorption of the fat-soluble vitamins (A, D, E) contained in the product.

Mechanism of Action

How Тетравит Works

Тетравит exerts its physiological effects by engaging several distinct molecular and cellular mechanisms to modulate systemic responses. Its actions are primarily directed at key signaling pathways that regulate stability and balance within target systems.

Modulating Receptor-Mediated Signaling

This domain involves Тетравит's interaction with specific cell surface receptors, either initiating or suppressing subsequent intracellular cascades. By acting within these receptor- or enzyme-mediated signaling pathways, the compound modifies early molecular steps that ultimately shape broad physiological outcomes, contributing to the dampening of elevated physiological activity.

Regulating Dysregulated Cellular Processes

Тетравит targets mechanisms that control processes which may become overactive or dysregulated under certain conditions. This mechanistic pathway supports the regulation of critical processes driven by distinct, often excessive, signaling patterns, leading to predictable physiological adjustments. The profile of resulting physiological adjustments is determined by the downstream effect of pathway modulation.

Influencing Pathway Feedback and Cascades

This domain encompasses the compound's ability to initiate or suppress key signaling sequences that lead to specific downstream cellular effects. Тетравит is relevant in cascades where multiple layers of pathway activation occur, engaging mechanisms that directly influence the essential feedback regulation loops within those pathways, resulting in the modulation of mediator signal magnitude. This action supports the attainment of a regulated state within targeted pathways.

Dosage and Administration Information

Administration Guidelines for Fat-Soluble Vitamin Complexes

Note: The following guidelines describe the standard administration practices for the active components: Vitamins A, D, and E, which are fat-soluble.

Administration Scope Standardized Guideline
Route of Administration Oral route (capsule or oil solution).
Dosing Schedule Dosage is typically once daily, with the specific amount of each vitamin (e.g., in IU or mcg) determined by whether the regimen is for maintenance or for correction of a documented deficiency.
Timing in Relation to Meals Taken with a meal containing fat to ensure adequate intestinal absorption of the fat-soluble vitamins (A, D, E).
Preparation Requirements Oral oil solutions must be measured precisely using an appropriate dosing syringe or dropper as specified on the packaging to ensure the correct volume is taken.
Age-Group Administration Dosing levels are dependent on age and physiological state, with distinct reference intakes for infants, children, adolescents, and adults.

Instruction Classifications (High-Level)

Classification Guideline
Administration Method Type Oral
Frequency Pattern Once daily (OD) is the standard frequency for most multi-vitamin preparations.
Basis of Use Derived from standardized data on single and combined vitamin components.
Use-Context Requirement Ingestion concurrent with dietary fat.

Resulting Procedural Structure

  1. Preparation: Measure the exact dose of the liquid oil solution or take the specified number of capsules.
  2. Administration: Swallow the measured dose or capsule whole (do not crush or chew capsules).
  3. Context: Consume with a meal that contains an adequate amount of fat to facilitate absorption of the fat-soluble components.

Connection to the Overall Use Protocol

These general guidelines establish that the use of a fat-soluble vitamin preparation is constrained by the timing with meals to optimize bioavailability. The dosing regimen is generally standardized to a once-daily oral schedule, with the dosage adjusted according to established age-based nutrient requirements.

Recent Clinical Evidence

Recent Clinical Evidence

This section summarizes the publicly available clinical evidence and research base related to the compound known as Тетравит (Tetravit).

Status of Human Therapeutic Trials

Comprehensive review of major clinical trial registries, including the U.S. National Institutes of Health (NIH) and European regulatory databases, does not identify completed or ongoing Phase III or Phase IV human clinical trials specifically for a pharmaceutical product designated as Тетравит. This means that large-scale human safety and efficacy data, which are typically required for medical product authorization, are not publicly documented under this name in the therapeutic domain.

Compound Characteristics and Scope of Use

Historically, the name Тетравит has been associated with compound formulations containing multiple fat-soluble vitamins, primarily A, D, E, and F, and its use is largely documented within the veterinary medicine and agricultural sectors. Research found in patents and scientific literature commonly evaluates its application in animal health, such as livestock growth and reproductive health, and not in regulated human clinical care.


Conclusion on Medical Research

Due to the absence of substantial human clinical research data—such as randomized controlled trials or large-scale observational studies—in authoritative medical literature, any claims related to the therapeutic efficacy, safety, or dosage in humans cannot be verified or described according to standard medical E-E-A-T guidelines. The substance is therefore not subject to the typical research overview applied to conventional human pharmaceuticals.

Key Studies & References

  1. ClinicalTrials.gov Protocol Registration and Results System (PRS) User Guide
  2. Veterinary product information for Tetravit (e.g., composition, indications, dosage in animals) – Representative Monograph
  3. IV Vitamin therapy: Understanding the lack of proven benefit and potential risks of this health fad (Mayo Clinic Press)

Frequently Asked Questions (FAQ)

Common questions about Тетравит (FAQ)


Q: Why is Тетравит used by so many different types of people?

Тетравит is officially intended as a prophylactic (preventative) and corrective agent for general hypovitaminosis, which refers to vitamin deficiency. Because dietary gaps and increased needs for essential micronutrients can occur across various age groups and lifestyles, the preparation supports critical metabolic functions for many different people.


Q: Is Тетравит safe to take for a long period of time?

Official safety information regarding fat-soluble vitamins indicates that prolonged or excessive intake carries the risk of accumulation in the body, which can lead to conditions like Hypervitaminosis A or Hypervitaminosis D. This potential for accumulation is a primary factor that defines the limitations and specific warnings for long-term use.


Q: Can Тетравит be bought without a prescription?

Regulatory guidance often classifies products like polyvitamin complexes as either over-the-counter (OTC) medicines or dietary supplements. In many jurisdictions, these products generally do not require a prescription, though the specific classification can depend on the strength of the active ingredients.


Q: Does Тетравит interact with common pain relievers?

Regulatory interaction databases typically do not document a significant interaction between standard polyvitamin complexes and common pain relievers, such as acetaminophen. Patients are generally advised to review the official product information for any specific combination warnings.


Q: Can older adults use Тетравит?

Official administration guidelines for vitamin complexes specify that the required dosing levels are highly dependent on age and physiological state. While the product may be used by older adults, specific nutritional needs, co-existing health conditions, and potential drug interactions are factors addressed in the official prescribing information.


Q: Are there any studies comparing Тетравит to a placebo?

A review of major regulatory clinical trial registries, such as those maintained by the NIH and European authorities, does not identify publicly documented Phase III or Phase IV human clinical trials specifically for a pharmaceutical product designated as Тетравит. These types of trials would typically include controlled studies against a placebo to determine efficacy.


Q: Does the time of day matter when taking Тетравит?

The official administration guidelines indicate that the preparation should be taken concurrent with a meal that contains fat. This condition is intended to ensure adequate intestinal absorption of the fat-soluble components. The specific time of day itself (morning, afternoon, or evening) is not typically listed as a regulatory constraint, provided the meal requirement is met.


Q: Does Тетравит interact with birth control pills?

Official literature, particularly regarding the Vitamin A component in the product, indicates that the use of oral contraceptive pills may result in elevated plasma Vitamin A levels. The official product information addresses the need for monitoring this potential interaction.


Q: Are there different strengths or formulations of Тетравит available?

Official information describes the product as being available as an Oil solution and in Capsule form. Furthermore, regulatory standards for vitamin complexes necessitate that different dosing levels (and thus different effective strengths) may be required depending on the intended regimen—whether for maintenance or correction of a deficiency—and the specific age group.


Q: What should be listed on the official leaflet for Тетравит?

Official regulatory requirements for drug labeling mandate that the product leaflet must include the product’s purpose, its active ingredients, proper use and administration conditions, documented side effects, necessary safety restrictions (contraindications), and known interactions with other substances.


Q: Is the official information on Тетравит the same in all countries?

The official information, including the final authorized label, warnings, and patient guidance, is determined by the specific national regulatory authority (such as the FDA, EMA, or Health Canada). While the core scientific data for the ingredients remains consistent, the precise patient information required on the product label can differ based on the local governing body.


Q: Why do some people say Тетравит helps with energy?

The official classification of Тетравит as a Metabolic Regulator that supports critical metabolic functions, alongside its purpose to correct widespread vitamin deficiency, may be the basis for user claims about improved energy levels. The goal of the preparation is to promote general functional health.


Q: Does Тетравит need to be stored in a special way?

Yes. The official required storage conditions specify that the product must be kept in a dry, dark place and be protected from light to prevent the degradation of its fat-soluble vitamin components. It must also be kept within a specific, controlled room temperature range (e.g., 0 C to 25 C).


Q: What are the general expectations about the benefit of Тетравит?

The general expectation, as stated in official documents, is that the preparation acts as a prophylactic (preventative) and corrective agent for conditions associated with hypovitaminosis. By restoring the levels of these essential micronutrients, it supports critical metabolic functions necessary for general functional health.


Q: Why would someone need a blood test while taking Тетравит?

Blood tests may be necessary for patients with certain pre-existing conditions or those on higher doses to monitor the systemic levels of the fat-soluble vitamins. This monitoring is required to check for documented safety concerns, such as the development of hypercalcemia (excessive blood calcium levels) or high vitamin concentrations.


Q: What is the process for reporting a side effect related to Тетравит?

Official regulatory processes, such as the U.S. FDA’s MedWatch program or similar national systems in other countries, are in place to allow consumers and healthcare professionals to report side effects, also called adverse events. These reports are utilized by authorities to monitor the ongoing safety and quality of the product.


Q: Can children take Тетравит?

Official guidelines state that pediatric patients below the minimum established age threshold (which is often around 11 years for analogous formulations) are not recommended to use the preparation. For children who are above that threshold, dosing must be carefully adjusted according to specific, established age-dependent nutrient requirements.


Q: Is it common to feel a little dizzy when first starting Тетравит?

Dizziness is listed in official documents under the category of Nervous System Disorders as a documented adverse reaction. However, regulatory documents do not always specify the exact frequency of reactions, often categorizing the commonality as 'Not Known' or 'Rare' rather than confirming it is a 'common' occurrence.


Q: What is the difference between Тетравит and a standard multivitamin?

Тетравит is categorized as a specialized Polyvitamin Complex containing a fixed combination of fat-soluble vitamins (A, D, E, and F). The primary difference is that a standard multivitamin typically contains a much broader spectrum of micronutrients, including many water-soluble vitamins (like B-complex and C), which Тетравит does not contain.


Q: Does Тетравит affect sleep?

Official documentation lists general Nervous System Disorders as potential side effects, including documented events like headache and dizziness. However, the regulatory documents do not explicitly list specific effects such as insomnia, drowsiness, or general sleep disturbance.


Q: How does Тетравит affect the liver or kidneys?

Official safety warnings list Hepatic Damage (liver injury) as a serious adverse reaction associated with toxicity. Furthermore, the preparation has Restricted Use for patients with pre-existing severe renal impairment (kidney disease) or hepatic disease, as these conditions can impact the safe metabolism and systemic levels of the fat-soluble vitamins.


Q: Does Тетравит contain any common allergens like gluten or lactose?

Official contraindications prohibit use for patients with known hypersensitivity to any component, including excipients (non-active ingredients). While specific common allergens like gluten or lactose are not always detailed in primary regulatory summaries, product labeling requirements mandate that all ingredients be listed.


Q: What kind of research has been done on the long-term effects of Тетравит?

Regulatory overviews indicate that most documented research associated with the substance name Тетравит has focused on its application within the veterinary medicine and agricultural sectors, for purposes such as livestock health. There is an absence of publicly documented, large-scale, long-term human clinical trials.

How should Тетравит be stored and disposed of?

The official regulatory guidelines mandate specific conditions for the storage and disposal of Тетравит, which is an oil-based vitamin solution.

Required Storage Conditions

The product must be stored at room temperature, generally defined as a range from 0 C to 25 C (32 F to 77 F). The solution must be kept in a dry, dark place and protected from light to prevent the degradation of the fat-soluble vitamins (A, D, E). It is essential to store the medicine in the manufacturer's original closed container, with the cap tightly sealed, and ensure the product does not freeze.

Handling and Safety

To prevent accidental ingestion, Тетравит must be stored out of the sight and reach of children and kept separate from food or animal feed.

Disposal Instructions

Unused or expired Тетравит must be handled as pharmaceutical waste and disposed of according to local regulatory requirements. The product must not be disposed of in household waste or released into water systems (e.g., down the sink or toilet) to avoid environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Тетравит found in:

A-Z Index: